| Methods |
Randomised crossover trial with allocation concealment.
No run in, 2 weeks of treatment with 1 week washout in between.
Single centre British study. |
| Participants |
38 patients ( 6 male, 32 female)
Inclusion criteria: patients with frequency, urgency and incontinance.
Exclusion criteria: not stated. |
| Interventions |
Group 1: Emepronium 200mg 3x/day
Group 2: Flavoxate 200mg 3x/day.
Number of paricipants in each group not stated. |
| Outcomes |
Urinalysis, urodynamic parameters, side effects, symptom assessment. |
| Notes |
Full text English.
Included 3 patients with UTI, 3 post prostatectomy, 2 diabetics, 18 had sphincter dysfunction, 1 had cystitis cystica. Not suitable for meta‐analysis. |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Low risk |
A ‐ Adequate |
